Health CanadaGeneral Alert
Important Safety Information on Concomitant Use of PAXIL or PAXIL CR and pimozid...
Published: July 22, 2005Recall ID: 24140Category: generalCountry: Canada
Reason for Recall / Hazard
Product safety
Product Description & Identification
Important Safety Information on Concomitant Use of PAXIL or PAXIL CR and pimozide (Orap) – GlaxoSmithKline Inc. – For Health Professionals
Additional Source Details
| Field | Value |
|---|---|
| N I D | 24140 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/important-safety-information-concomitant-use-paxil-or-paxil-cr-and-pimozide-orap |
| Issue | Product safety |
| Title | Important Safety Information on Concomitant Use of PAXIL or PAXIL CR and pimozide (Orap) – GlaxoSmithKline Inc. – For Health Professionals |
| Archived | 1 |
| Category | Drugs |
| Last updated | 2005-07-22 |
| Organization | Marketed health products |